|
Published by: Datamonitor
Published: Jul. 31, 2008 - 185 Pages
Table of Contents
- Chapter 1 EXECUTIVE SUMMARY
- Summary Market Level - OTC Healthcare
- Summary category level - Analgesics
- Summary category level - Cough and Cold Preparations
- Summary category level - Traditional Medicines
- Summary category level - First Aid Kits
- Summary category level - Indigestion Preparations
- Summary category level - Vitamins and Minerals
- Summary category level - Plasters & Bandages
- Summary category level - Medicated Skin Products
- Summary category level - Other OTC Healthcare Products
- Summary category level - Topical OTC Medicines
- Chapter 2 INTRODUCTION
- What is this report about?
- How to use this report
- Market Definition
- Chapter 3 MARKET OVERVIEW
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 4 LEADING COMPANY PROFILES
- Bayer AG
- Pfizer Inc
- Chapter 5 CATEGORY ANALYSIS - ANALGESICS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 15 COUNTRY COMPARISON
- Value
- Market Share
- Chapter 16 NEW PRODUCT DEVELOPMENT
- Product launches over time
- Recent product launches
- Chapter 17 GERMANY SOCIOECONOMIC PROFILE
- Country Overview
- Key Facts
- Political Overview
- Germany Economic Overview
- Chapter 18 GERMANY MACROECONOMIC PROFILE
- Macroeconomic Indicators
- Chapter 19 RESEARCH METHODOLOGY
- Methodology overview
- Secondary research
- Market modelling
- Primary research
- Data finalisation
- Ongoing research
- Chapter 20 APPENDIX
- Future readings
- How to contact experts in your industry
- LIST OF FIGURES
- Figure 1: Germany OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 2: Germany OTC Healthcare category growth comparison, by value, 2001-2011
- Figure 3: Germany OTC Healthcare company share, by value, 2005-2006 (%)
- Figure 4: Germany Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 5: Germany Analgesics category growth comparison, by value, 2001-2011
- Figure 6: Germany Analgesics company share, by value, 2005-2006 (%)
- Figure 7: Germany Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 8: Germany Cough and Cold Preparations category growth comparison, by value, 2001-2011
- Figure 9: Germany Cough and Cold Preparations company share, by value, 2005-2006 (%)
- Figure 10: Germany Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 11: Germany First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 12: Germany First Aid Kits company share, by value, 2005-2006 (%)
- Figure 13: Germany Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 14: Germany Indigestion Preparations category growth comparison, by value, 2001-2011
- Figure 15: Germany Indigestion Preparations company share, by value, 2005-2006 (%)
- Figure 16: Germany Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 17: Germany Vitamins and Minerals category growth comparison, by value, 2001-2011
- Figure 18: Germany Vitamins and Minerals company share, by value, 2005-2006 (%)
- Figure 19: Germany Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 20: Germany Plasters & Bandages category growth comparison, by value, 2001-2011
- Figure 21: Germany Plasters & Bandages company share, by value, 2005-2006 (%)
- Figure 22: Germany Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 23: Germany Medicated Skin Products category growth comparison, by value, 2001-2011
- Figure 24: Germany Medicated Skin Products company share, by value, 2005-2006 (%)
- Figure 25: Germany Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 26: Germany Other OTC Healthcare Products category growth comparison, by value, 2001-2011
- Figure 27: Germany Other OTC Healthcare Products company share, by value, 2005-2006 (%)
- Figure 28: Germany Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
- Figure 29: Germany Topical OTC Medicines category growth comparison, by value, 2001-2011
- Figure 30: Germany Topical OTC Medicines company share, by value, 2005-2006 (%)
- Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
- Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
- Figure 33: Map of Germany
- Figure 34: Annual data review process
- LIST OF TABLES
- Table 1: OTC Healthcare category definitions
- Table 2: Germany OTC Healthcare value, 2001-2006 (EUR m, nominal prices)
- Table 3: Germany OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices)
- Table 4: Germany OTC Healthcare value, 2001-2006 (US$ m nominal prices)
- Table 5: Germany OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
- Table 6: Germany OTC Healthcare brand share, by value, 2005-2006 (%)
- Table 7: Germany OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices)
- Table 8: Germany OTC Healthcare company share by value, 2005-2006 (%)
- Table 9: Germany OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices)
- Table 10: Germany OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 11: Germany OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 12: Germany OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 13: Germany OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 14: Bayer AG Key Facts
- Table 15: Pfizer Inc Key Facts
- Table 16: Germany Analgesics value, 2001-2006 (EUR m, nominal prices)
- Table 17: Germany Analgesics value forecast, 2006-2011 (EUR m, nominal prices)
- Table 18: Germany Analgesics value, 2001-2006 (US$ m nominal prices)
- Table 19: Germany Analgesics value forecast, 2006-2011 (US$ m nominal prices)
- Table 20: Germany Analgesics brand share, by value, 2005-2006 (%)
- Table 21: Germany Analgesics value, by brand 2005-2006 (EUR m nominal prices)
- Table 22: Germany Analgesics company share by value, 2005-2006 (%)
- Table 23: Germany Analgesics value, by company, 2005-2006 (EUR m nominal prices)
- Table 24: Germany Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 25: Germany Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 26: Germany Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 27: Germany Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 28: Germany Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices)
- Table 29: Germany Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices)
- Table 30: Germany Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
- Table 31: Germany Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 32: Germany Cough and Cold Preparations brand share, by value, 2005-2006 (%)
- Table 33: Germany Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices)
- Table 34: Germany Cough and Cold Preparations company share by value, 2005-2006 (%)
- Table 35: Germany Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices)
- Table 36: Germany Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 37: Germany Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 38: Germany Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 39: Germany Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 40: Germany Traditional Medicines value, 2001-2006 (EUR m, nominal prices)
- Table 41: Germany Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices)
- Table 42: Germany Traditional Medicines value, 2001-2006 (US$ m nominal prices)
- Table 43: Germany Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 44: Germany Traditional Medicines brand share, by value, 2005-2006 (%)
- Table 45: Germany Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices)
- Table 46: Germany Traditional Medicines company share by value, 2005-2006 (%)
- Table 47: Germany Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices)
- Table 48: Germany Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 49: Germany Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 50: Germany Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 51: Germany Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 52: Germany First Aid Kits value, 2001-2006 (EUR m, nominal prices)
- Table 53: Germany First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices)
- Table 54: Germany First Aid Kits value, 2001-2006 (US$ m nominal prices)
- Table 55: Germany First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
- Table 56: Germany First Aid Kits brand share, by value, 2005-2006 (%)
- Table 57: Germany First Aid Kits value, by brand 2005-2006 (EUR m nominal prices)
- Table 58: Germany First Aid Kits company share by value, 2005-2006 (%)
- Table 59: Germany First Aid Kits value, by company, 2005-2006 (EUR m nominal prices)
- Table 60: Germany First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 61: Germany First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 62: Germany First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 63: Germany First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 64: Germany Indigestion Preparations value, 2001-2006 (EUR m, nominal prices)
- Table 65: Germany Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices)
- Table 66: Germany Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
- Table 67: Germany Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 68: Germany Indigestion Preparations brand share, by value, 2005-2006 (%)
- Table 69: Germany Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices)
- Table 70: Germany Indigestion Preparations company share by value, 2005-2006 (%)
- Table 71: Germany Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices)
- Table 72: Germany Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 73: Germany Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 74: Germany Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 75: Germany Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 76: Germany Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices)
- Table 77: Germany Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices)
- Table 78: Germany Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
- Table 79: Germany Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
- Table 80: Germany Vitamins and Minerals brand share, by value, 2005-2006 (%)
- Table 81: Germany Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices)
- Table 82: Germany Vitamins and Minerals company share by value, 2005-2006 (%)
- Table 83: Germany Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices)
- Table 84: Germany Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 85: Germany Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 86: Germany Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 87: Germany Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 88: Germany Plasters & Bandages value, 2001-2006 (EUR m, nominal prices)
- Table 89: Germany Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices)
- Table 90: Germany Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
- Table 91: Germany Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
- Table 92: Germany Plasters & Bandages brand share, by value, 2005-2006 (%)
- Table 93: Germany Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices)
- Table 94: Germany Plasters & Bandages company share by value, 2005-2006 (%)
- Table 95: Germany Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices)
- Table 96: Germany Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 97: Germany Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 98: Germany Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 99: Germany Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 100: Germany Medicated Skin Products value, 2001-2006 (EUR m, nominal prices)
- Table 101: Germany Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices)
- Table 102: Germany Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
- Table 103: Germany Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 104: Germany Medicated Skin Products brand share, by value, 2005-2006 (%)
- Table 105: Germany Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices)
- Table 106: Germany Medicated Skin Products company share by value, 2005-2006 (%)
- Table 107: Germany Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices)
- Table 108: Germany Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 109: Germany Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 110: Germany Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 111: Germany Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 112: Germany Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices)
- Table 113: Germany Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices)
- Table 114: Germany Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
- Table 115: Germany Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 116: Germany Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
- Table 117: Germany Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices)
- Table 118: Germany Other OTC Healthcare Products company share by value, 2005-2006 (%)
- Table 119: Germany Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices)
- Table 120: Germany Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 121: Germany Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 122: Germany Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 123: Germany Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 124: Germany Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices)
- Table 125: Germany Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices)
- Table 126: Germany Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
- Table 127: Germany Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 128: Germany Topical OTC Medicines brand share, by value, 2005-2006 (%)
- Table 129: Germany Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices)
- Table 130: Germany Topical OTC Medicines company share by value, 2005-2006 (%)
- Table 131: Germany Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices)
- Table 132: Germany Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
- Table 133: Germany Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
- Table 134: Germany Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 135: Germany Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 136: Global OTC Healthcare market value, 2006
- Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
- Table 138: Leading players - Top 5 countries
- Table 139: Germany OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
- Table 140: Germany OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006
- Table 141: Germany OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
- Table 142: Germany OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
- Table 143: Germany OTC Healthcare new product launches (reports) - Recent 5 launches
- Table 144: Germany Key Facts
- Table 145: Germany population, by age group, 2000-2005 (millions)
- Table 146: Germany population forecast, by age group, 2005-2010 (millions)
- Table 147: Germany population, by gender, 2000-2005 (millions)
- Table 148: Germany population forecast, by gender, 2005-2010 (millions)
- Table 149: Germany real GDP, 2000-2005 (EUR bn, 2005 prices)
- Table 150: Germany real GDP forecast, 2005-2010 (EUR bn, 2005 prices)
- Table 151: Germany nominal GDP, 2000-2005 (EUR bn, nominal prices)
- Table 152: Germany real GDP, 2000-2005 (US$ bn, 2005 prices)
- Table 153: Germany real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
- Table 154: Germany consumer price index, 2000-2005 (2000=100)
- Table 155: Germany consumer price index, 2005-2010 (2000=100)
- Table 156: Germany exchange rate, 2000-2005
AbstractIntroduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Germany. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights
The market for OTC Healthcare in Germany increased between 2001-2006, growing at an average annual rate of 0.7%.
The leading company in the market in 2006 was Bayer AG. The second-largest player was Pfizer Inc with GlaxoSmithKline Plc in third place.
Reasons to Purchase- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers' consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|